MDxHealth (MDXH) Liabilities and Shareholders Equity (2020 - 2026)

MDxHealth has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $160.8 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $160.8 million, down 8.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $463.2 million (down 25.34% YoY), and the FY2025 annual result was $148.0 million, down 5.96% from the prior year.
• Liabilities and Shareholders Equity came in at $160.8 million for Q1 2026 at MDxHealth, up from $148.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $174.8 million in Q1 2025 to a low of $162501.0 in Q2 2025.
• The 5-year median for Liabilities and Shareholders Equity is $139.1 million (2023), against an average of $133.3 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 58.69% in 2022 and plunged 99.88% in 2025, its largest moves.
• MDxHealth's Liabilities and Shareholders Equity stood at $119.1 million in 2022, then rose by 8.39% to $129.1 million in 2023, then grew by 21.84% to $157.3 million in 2024, then dropped by 5.96% to $148.0 million in 2025, then climbed by 8.7% to $160.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $160.8 million (Q1 2026), $148.0 million (Q4 2025), and $154.3 million (Q3 2025), per Business Quant data.